SE Tylose – your best partner
Being a part of the Shin-Etsu group, we unite innovation and tradition. Our highly qualified team continuously rethinks TYLOSE® and TYLOPUR® to suit your requirements in a world of products and applications.
Being a part of the Shin-Etsu group, we unite innovation and tradition. Our highly qualified team continuously rethinks TYLOSE® and TYLOPUR® to suit your requirements in a world of products and applications.
TYLOSE enables the manufacturing of modern and efficient construction materials.
Read moreTYLOSE acts as highly effective protective colloid in these processes and facilitates outstanding results.
Read moreCellulose excipients can make a valuable contribution to various areas of pharmaceutical technology.
Read morePersonal Care products include all areas of nurturing and decorative cosmetics.
Read moreCellulose derivatives are highly suitable polymers for hard capsule shells and filling.
Read moreTYLOPUR Nutra grades excel in nutraceutical and nutritional applications.
Read more
We mainly employ personnel with typical training qualifications in chemistry, e.g. chemical technicians.
The renewable primary raw material cellulose from wood and cotton is converted into various water soluble types of cellulose that are used in virtually all parts of daily life.
Our product portfolio is designed to meet current and future needs of business and society and our innovative products help to make life better!
Our customer service objective is to ensure your ordering experience is efficient and accurate. We will manage logistic for customers in other regions independent from Shin-Etsu´s production sites.
Quicklinks:
We are approaching the end of 2023. It was a very exciting year full of activities and information to share with you. With this Newsletter we would like to highlight the most important ones:
1. Together with four partnering companies we organised the 4th Shin-Etsu Technical Seminar in May 2023 at our SE Tylose site
in Wiesbaden, Germany. Now the protocols of the four technologies demonstrated during the seminar are available upon request through our website.
2. Shin-Etsu ́s efforts in mitigating the risk of nitrosamine formation in solid oral dosage forms.
3. Our research activities:
– Recently published article in a peer reviewed journal,
– Six posters presented this year at AAPS PharmSci 360 in Orlando, Florida, USA – ODT blog article posted.
We would be delighted to share more details with you so please do not hesitate to contact us!
